EGAGenomicsN/Ahttps://ega-archive.org/datasets/EGAD0001000233084EGA dataset EGAD00010002330EGATherapy, Breast Carcinoma, Human Mammary Neoplasm, primary breast cancer, Carcinoma, malignant tumor of the breast, Breast Carcinomas, "breast neoplasm" EXACT [MTH:120], chemotherapy, Blood, Neoplasms, total expressed protein, mammary neoplasm, Mammary Cancers, Human Mammary Neoplasms, pharmacotherapy, Pharmacotherapies, Blood Serum, Serum, Tumor, "breast tumor" EXACT [NCI2004_11_17:C2910], Fs(3)Sz11, Chemotherapies, Human, Breast Malignant Neoplasm, Breast Malignant Tumor, "neoplasm of breast (disorder)" EXACT [SNOMEDCT_2005_07_31:126926005], Mammary Carcinomas, Breast Tumor, Neoplasm, Chemotherapy, Human Mammary Carcinoma, "mammary tumor" EXACT [CSP2005:2016-0671], NOS, breast tumor, cancer of the breast, DmF2, Fs(3)Hor, Malignant Neoplasm of Breast, Drug Therapies, lod, Carcinomas, BC, Mammary Neoplasms, malignant neoplasm of breast, DmelCG2684, Human Mammary, Breast Neoplasm, Pharmacotherapy, Mammary Neoplasm, Mammary Carcinoma, Human Mammary Carcinomas, Cancers, Breast Malignant Neoplasms., NTef2, "mammary neoplasm" RELATED [], Lds, early, Cancer of the Breast, Drug, breast cancer, cancer of breast, Horka, Malignant Tumor of Breast, Mammary, Mammary Cancer, Breast Tumors, Breast Cancer, CG2684, Therapies, Breast Malignant Tumors, Fs(3)Horka, Cancer of Breast, pharmacologic therapy, Breast, mammary cancer, cancer, mammary tumor, Proteomes, Serums, breast, Tumors, Cancerprimary breast cancer, Healthy Volunteer, malignant tumor of the breast, PhrB photolyase activity, Participants, chemotherapy, Blood, Neoplasms, mammary neoplasm, Mammary Cancers, Human Mammary Neoplasms, pharmacotherapy, Pharmacotherapies, Human Volunteers, Serum, Tumor, photoreactivating enzyme activity, pigmented epithelium, prevention, Chemotherapies, Human, Breast Malignant Tumor, Healthy Subjects, "neoplasm of breast (disorder)" EXACT [SNOMEDCT_2005_07_31:126926005], Breast Tumor, Normal Volunteers, "mammary tumor" EXACT [CSP2005:2016-0671], breast tumor, 3, cancer of the breast, stratum pigmentosa retinae, Participant, NUP96, epithelium, prevention and control, Drug Therapies, BC, Mammary Neoplasms, malignant neoplasm of breast, Human Mammary, MOS3, deoxyribocyclobutadipyrimidine pyrimidine-lyase activity, reference sample, PRECOCIOUS, Mammary Neoplasm, Mammary Carcinoma, Human Mammary Carcinomas, pigmented retina, F23A5.3, Normal Volunteer, DNA cyclobutane dipyrimidine photolyase activity, Cancer of the Breast, SUPPRESSOR OF AUXIN RESISTANCE 3, preventive measures, set, cancer of breast, grupos, Healthy Participants, Malignant Tumor of Breast, Clients, Mammary, Mammary Cancer, Normal, Therapies, Breast, mammary cancer, mammary tumor, Breast Malignant Neoplasms, F23A5_3, Controlled, Tumors, Cancer, Therapy, PRE, Breast Carcinoma, Human Mammary Neoplasm, Carcinoma, Controlling, preventive therapy, Breast Carcinomas, "breast neoplasm" EXACT [MTH:120], grupo, deoxyribonucleic cyclobutane dipyrimidine photolyase activity, Blood Serum, "breast tumor" EXACT [NCI2004_11_17:C2910], Client, Subjects, Volunteers, group, Breast Malignant Neoplasm, MODIFIER OF SNC1, retinal pigment, Mammary Carcinomas, deoxyribonucleic photolyase activity, Neoplasm, dipyrimidine photolyase (photosensitive), Human Mammary Carcinoma, Chemotherapy, NOS, Malignant Neoplasm of Breast, retinal pigment layer, Carcinomas, Healthy Participant, Breast Neoplasm, RPE, Volunteer, Pharmacotherapy, ensemble, photolyase activity, Healthy Subject, prophylaxis, Rest, Human Volunteer., Cancers, "mammary neoplasm" RELATED [], Healthy, p. pigmentosa retinae, Drug, phr A photolyase activity, DNA-photoreactivating enzyme, Patient, breast cancer, control, Breast Tumors, Breast Cancer, Subject, Breast Malignant Tumors, Cancer of Breast, pharmacologic therapy, deoxyribonucleate pyrimidine dimer lyase (photosensitive), cancer, groupe, Serums, breast, GruppefalseSerum Proteome Profiling Identifies Early Markers of Therapeutic Response to Neoadjuvant Chemotherapy of Breast CancerWe performed a proteomic serum profiling of patients with non-metastasized breast cancer (BC) who received neoadjuvant chemotherapy (NACT). Samples were collected at three timepoints during NACT. Furthermore, we compared serum samples of BC patients pre-NACT to a control group of healthy volunteers.2023-01-11 12:44:31EGAD000100023309606EGAC00001002656EGAS00001006228